This could be analagous to the use of apabetalone for COVID-19. However, if and when an apabetalone trial is run hopefully it achieves statistical significance for the primary endpoint.
https://www.globenewswire.com/news-release/2021/01/23/2163109/0/en/Colchicine-reduces-the-risk-of-COVID-19-related-complications.html